Serving clients throughout PA, NJ, NY, and MD. If you received Depo-Provera injections and were later diagnosed with a meningioma or other brain tumor, you may be entitled to compensation from Pfizer and other manufacturers. Siddons Law Firm is reviewing Depo-Provera injury claims. Call (610) 255-7500 for a free, confidential case review.
Key Takeaways
- In December 2025 the FDA added a new warning label to Depo-Provera linking long-term use to an increased risk of meningioma, a type of brain tumor.
- Women who received Depo-Provera injections for at least one year and were later diagnosed with a meningioma may qualify for compensation.
- Claims are being consolidated in federal MDL No. 3140 and in several state coordinated proceedings.
- There is no cost to have your case evaluated. You pay nothing unless we recover money for you.
What Is Depo-Provera?
Depo-Provera (medroxyprogesterone acetate) is a long-acting injectable contraceptive manufactured by Pfizer. A single injection prevents pregnancy for about three months. It has been on the U.S. market since 1992 and is used by millions of women each year, particularly women who want a convenient alternative to daily birth control pills.
The Link Between Depo-Provera and Brain Tumors
Meningiomas are tumors that develop from the meninges, the membranes that surround the brain and spinal cord. While most meningiomas are noncancerous, they can still cause serious neurological symptoms — headaches, vision problems, seizures, cognitive changes, personality changes, and weakness — and they frequently require brain surgery or radiation to remove.
A 2024 peer-reviewed study published in The BMJ found that prolonged use of medroxyprogesterone acetate was associated with a significantly elevated risk of intracranial meningioma. In response to that study and related safety signals, the FDA updated Depo-Provera’s label in December 2025 to warn patients and prescribers about the brain tumor risk. That label change is central to the litigation: plaintiffs allege that Pfizer had access to the same research years earlier and failed to warn U.S. patients in a timely manner.
Who May Qualify
You may have a Depo-Provera claim if all of the following apply:
- You received Depo-Provera (or a generic medroxyprogesterone acetate injection) on at least four occasions — generally one year or more of use.
- You were later diagnosed with a meningioma or other intracranial tumor.
- You can document both the Depo-Provera use and the tumor diagnosis through medical and pharmacy records.
- The diagnosis occurred within the statute of limitations for your state (typically two years in PA and NJ, three years in NY and MD, measured from when the link between the drug and the injury became known).
We obtain your records for you at no cost as part of the initial case evaluation.
Compensation Available
Depo-Provera plaintiffs may be entitled to recover:
- Past and future medical expenses, including brain surgery, radiation, and long-term monitoring
- Lost wages and reduced earning capacity
- Pain and suffering, emotional distress, and loss of enjoyment of life
- Loss of consortium (for the plaintiff’s spouse)
- Wrongful death damages where the tumor was fatal
Individual values vary based on tumor location, treatment required, and long-term prognosis. Settlement grids in cases like these typically pay more for surgical tumors and for women who were younger at diagnosis.
How Depo-Provera Cases Work
Depo-Provera claims are handled as a mass tort rather than a class action. Each plaintiff keeps her own claim and her own recovery. Cases are consolidated in a federal MDL for shared discovery efficiency, but bellwether trials test individual verdicts and drive settlement negotiations. Most plaintiffs will not need to travel or testify in person; the vast majority of cases resolve through a settlement matrix once bellwether verdicts come in.
Why Choose Our Firm
Siddons Law Firm represents Depo-Provera clients throughout Pennsylvania, New Jersey, New York, and Maryland. We work with nationally recognized pharmaceutical co-counsel on complex MDL cases, meaning your case is backed by the same expert neurologists, radiologists, and scientific consultants driving the biggest MDL verdicts in the country. You get a local lawyer who returns your calls and the firepower of a national pharmaceutical litigation team behind you. Contingency fee — no money up front, no fees unless we recover compensation for you.
Frequently Asked Questions
How long do I have to file a Depo-Provera claim?
In PA and NJ, two years from the date you knew or reasonably should have known that Depo-Provera caused your tumor. In NY and MD, three years. The clock often doesn’t start at the first injection — it starts when the link between the drug and the injury became apparent.
I don’t remember exact dates. Can I still file?
Yes. Pharmacy records, insurance claims data, and OB/GYN records are usually enough to document the injections. We obtain these for you at no cost.
What if I received a generic, not brand-name Depo-Provera?
You may still qualify. Claims may be available against the generic manufacturer, Pfizer as the original brand-name manufacturer, or both depending on state law.
Does my tumor need to have been surgically removed?
No. Women with meningiomas that are being actively monitored (not yet removed), treated with radiation, or that were surgically removed may all qualify.
Start Your Depo-Provera Case Today
Call (610) 255-7500 or email msiddons@siddonslaw.com for a free, confidential case review. Serving clients throughout PA, NJ, NY, and MD.